In diabetes, pancreatic beta cells in a pro-inflammatory environment release EVs with CXCL10 on the surface, which induces failure of neighbouring beta cells through activation of the CXCL10/CXCR3 axis [49]. Here, CXCL10 is linked to diabetes mellitus.